Ark Biosciences taps WuXI STA for CMC development

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/otawa)
(Image: Getty/otawa)

Related tags: CMC, RSV, Wuxi apptec, WuXi STA, marketing authorization

WuXi AppTec subsidiary, STA Pharmaceutical partners with Ark Biosciences for CMC development of RSV therapy.

Ark Biosciences will use China’s Marketing Authorization Holder (MAH) system to accelerate its drug development.

Through the partnership with WuXi STA, Ark Biosciences will be able to optimize manufacturing processes, reduce commercial production costs, mitigate business risk, and improve operational efficiency.

The contract development and manufacturing organization (CDMO), WuXi STA, will provide its integrated process R&D manufacturing solution for the chemistry, manufacturing and controls (CMC) development for Ark’s drug candidate and current pipeline.

Ark Bioscience has a pipeline of active discovery programs and in-licensed drug assets for clinical development, including its drug candidate, Ziresovir (AK0529), an F-protein inhibitor for the treatment of respiratory syncytial virus (RSV). The therapy has completed three Phase I clinical trials and is currently in a global phase II clinical trial.

WuXi STA has been in collaboration with companies to enable domestic innovative drug development.

Related news

Show more

Related products

show more

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Innovations in OSD

Innovations in OSD

Recorded the 06-Oct-2020 | Webinar

This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Related suppliers

Follow us


View more